2010
DOI: 10.1016/j.canlet.2009.08.014
|View full text |Cite
|
Sign up to set email alerts
|

An unusual DNA binding compound, S23906, induces mitotic catastrophe in cultured human cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
22
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
4
2
1

Relationship

2
5

Authors

Journals

citations
Cited by 21 publications
(23 citation statements)
references
References 34 publications
1
22
0
Order By: Relevance
“…By cisplatin treatment, WI-38 cells arrest largely in G1 and few cells expressed cyclin B1 protein, which would be critical for activation of Cdk1 and entry into mitosis. There are numerous genetic and experimental examples of how inhibition of Chk1 protein leads to entry into mitosis 45,46 or micronuclei formation. 42 It is noteworthy, however, that the simplest approach such as re-introducing functional p53 in a cancer cell line does not prevent mitotic catastrophe, or likely checkpoint adaptation.…”
Section: Micronuclei Cause Additional Damage To Dnamentioning
confidence: 99%
“…By cisplatin treatment, WI-38 cells arrest largely in G1 and few cells expressed cyclin B1 protein, which would be critical for activation of Cdk1 and entry into mitosis. There are numerous genetic and experimental examples of how inhibition of Chk1 protein leads to entry into mitosis 45,46 or micronuclei formation. 42 It is noteworthy, however, that the simplest approach such as re-introducing functional p53 in a cancer cell line does not prevent mitotic catastrophe, or likely checkpoint adaptation.…”
Section: Micronuclei Cause Additional Damage To Dnamentioning
confidence: 99%
“…We also demonstrated that Chk1 was active, as shown by Chk1 phosphorylation on Ser345, which is the site phosphorylated by the upstream kinases ATM and ATR (Capasso et al, 2002;Zhao and Piwnica-Worms, 2001). A wide range of genotoxic compounds, including novel synthetic molecules are recognized by cells and activate histone H2AX and Chk1 (Cahuzac et al, 2010). Under conditions of genotoxicity, including those induced by topoisomerase I inhibition, cells will arrest in G2 phase of the cell cycle (Shao et al, 1997).…”
Section: Chk1 Inhibitors In Cell-based Assaysmentioning
confidence: 85%
“…Chk1 is activated in cells that have been treated with genotoxic cancer drugs, including camptothecin derivatives (Cliby et al, 2002;Eastman et al, 2002), gemcitabine (Morgan et al, 2005), cisplatin (Zhao and Piwnica-Worms, 2001), etoposide (Cliby et al, 2002) and alkylating agents (Cahuzac et al, 2010). Because Chk1 activity is part of the cellular response to anti-cancer drugs, it suggests that inactivation of Chk1 might provide a clinical benefit.…”
Section: Discussionmentioning
confidence: 98%
See 2 more Smart Citations